LCGC UST
|Articles|September 1, 2008

The Application Notebook

  • The Application Notebook-09-01-2008
  • Volume 0
  • Issue 0

Analysis of Voglibose in Pharmaceutical Formulations by HPLC with Post-Column Derivatization

Voglibose is an Alpha-Glucosidase inhibitor widely used for the treatment of diabetes. Alpha-glucosidase inhibitors are agents that delay the glucose absorption at the intestinal level and thereby prevent sudden surge of glucose after a meal. Voglibose is the safest and most effective drug of its class.

Maria Ofitserova Ph.D., Sareeta Nerkar, Ph. D., and Michael Pickering Ph.D., Pickering Laboratories

Voglibose is an Alpha-Glucosidase inhibitor widely used for the treatment of diabetes. Alpha-glucosidase inhibitors are agents that delay the glucose absorption at the intestinal level and thereby prevent sudden surge of glucose after a meal. Voglibose is the safest and most effective drug of its class.

Table I: Repeatability studies for different concentration levels

Since Voglibose has no UV chromophore, post-column deriv-atization is employed to produce a fluorescent derivative.

Figure 1

This abstract describes a very sensitive and robust analytical method for the analysis of Voglibose in pharmaceutical tablets. Simple sample preparation and fast analysis time allow for using this method in high throughput environments.

Figure 2

Pickering Laboratories, Inc.

1280 Space Park Way

Mountain View, California 94043

Tel (650) 694-6700

Email: marketing@pickeringlabs.com

www.pickeringlabs.com


Related to this article

Best of the Week: From Olive Waste to mRNA Vaccines
This week's Chromatography Online highlights include olive waste antioxidant recovery, food and tea analysis, EV isolation, mRNA vaccine purification, perfusion chromatography for oligonucleotides, mass spectrometry in teaching and career advice from “Women in Chromatography.”